Compare BRO & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BRO | WAT |
|---|---|---|
| Founded | 1939 | 1958 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.2B | 22.5B |
| IPO Year | N/A | 1995 |
| Metric | BRO | WAT |
|---|---|---|
| Price | $80.37 | $374.13 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 15 |
| Target Price | $100.43 | ★ $390.67 |
| AVG Volume (30 Days) | ★ 2.4M | 632.3K |
| Earning Date | 01-26-2026 | 11-04-2025 |
| Dividend Yield | ★ 0.82% | N/A |
| EPS Growth | N/A | ★ 3.82 |
| EPS | 3.31 | ★ 10.88 |
| Revenue | ★ $5,350,000,000.00 | $3,105,638,000.00 |
| Revenue This Year | $27.36 | $7.96 |
| Revenue Next Year | $23.03 | $6.32 |
| P/E Ratio | ★ $24.24 | $34.76 |
| Revenue Growth | ★ 17.50 | 6.90 |
| 52 Week Low | $76.17 | $275.05 |
| 52 Week High | $125.68 | $423.56 |
| Indicator | BRO | WAT |
|---|---|---|
| Relative Strength Index (RSI) | 48.53 | 42.31 |
| Support Level | $80.04 | $372.93 |
| Resistance Level | $82.58 | $397.55 |
| Average True Range (ATR) | 1.62 | 9.27 |
| MACD | 0.41 | -4.19 |
| Stochastic Oscillator | 61.79 | 6.20 |
Brown & Brown Inc is a diversified insurance agency, wholesale brokerage, insurance programs, and service. The Company markets and sells insurance products and services, in the property, casualty, and employee benefits areas. It provides customers with non-investment insurance contracts, as well as other targeted, customized risk management products and services. It has four reportable segments; the Retail segment; the Programs segment; the Wholesale Brokerage segment and; the Services segment. It generates the majority of its revenue from the Retail segment which provides insurance products and services to commercial, public and quasi-public, and Others through automobile dealer services F&I businesses. Its geographic area is U.S., U.K., the Republic of Ireland, Canada, and Others.
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.